News | January 24, 2011

Stent Graft Relining System Offers Lower Delivery Profile

January 24, 2011 – A new device for treating peripheral artery disease (PAD) is now available in Europe. W.L. Gore and Associates announced the availability of its Viabahn Endoprosthesis on a lower profile delivery system at the Leipzig Interventional Course in Germany.

The device is designed to treat PAD percutaneously by relining the native vessel. The stent graft enables a reduction in delivery profile to 6 French for 5 and 6 mm devices and 7 French for 7 and 8 mm devices. It is delivered over a 0.18 inch or 0.14 inch guidewire. The reduced delivery profile will provide interventionalists with greater options for treating stenosis and occlusions of the superficial femoral artery (SFA) and other peripheral arteries where a small access size is critical.

It is the only device of its kind in Europe and is approved for endovascular grafting of peripheral arteries. The new delivery catheter is available in a 120 cm length and incorporates the Propaten Bioactive Surface, which utilizes end-point immobilization of derivatized heparin to the endoprosthesis luminal surface. This preserves the heparin bioactive sites such that they remain free to interact with the blood at the device surface without being consumed.

“A reduction in profile seen in the Gore Viabahn Endoprosthesis means easier endovascular delivery of the device to treat occlusions in the superficial femoral artery (SFA) and other tough to reach locations in patients where a small access size is critical and includes all of the historical benefits of heparin-bonded Propaten Bioactive Surface,” said Daniele Savio, M.D., vascular and interventional radiology, San Giovanni Bosco Hospital, Torino, Italy.

It is constructed with a durable, reinforced, biocompatible, ePTFE liner attached to an external nitinol stent structure. The excellent flexibility enables it to better traverse tortuous areas of the SFA and peripheral arteries and conforms to these arteries and withstands complex mechanical motion.

For more information: www.goremedical.com

Related Content

News | Drug-Eluting Balloons| August 15, 2017
Surmodics Inc. announced receipt of an investigational device exemption (IDE) from the U.S. Food and Drug...
Ra Medical Systems Granted Broad Patent for DABRA Catheter
News | Peripheral Artery Disease (PAD)| August 09, 2017
August 9, 2017 — Ra Medical Systems announced that the United States Patent and Trademark Office (USPTO) has granted
The LimFlow Percutaneous Deep Vein Arterialization System (pDVA) converts veins into arteries to restore blood flow in critical limb ischemia (CLI).

The LimFlow Percutaneous Deep Vein Arterialization System (pDVA) converts veins into arteries to restore blood flow in critical limb ischemia (CLI). This image shows how the covered stents used with the system connect to create a new arterial pathway.

News | Peripheral Artery Disease (PAD)| August 02, 2017
Aug.
Spectranetics Announces FDA Approval of Stellarex Drug-Coated Balloon
Technology | Drug-Eluting Balloons| July 26, 2017
The Spectranetics Corp. announced receipt of U.S. Food and Drug Administration (FDA) pre-market approval (PMA) of the...
First European Patient Enrolled in Intact Vascular's TOBA II BTK Trial
News | Stents Peripheral| July 26, 2017
Intact Vascular Inc. recently announced that its Tack Optimized Balloon Angioplasty II Below the Knee (TOBA II BTK)...
Sponsored Content | Videos | Peripheral Artery Disease (PAD)| July 25, 2017
This video case study, provided by Gore Medical, is titled "Tackling Complex Cases in Dialysis Access," by John Ross,
Gore Announces First-in-Human Use of Gore TAG Conformable Thoracic Stent Graft
News | Stent Grafts| July 17, 2017
W. L. Gore & Associates Inc. announced the first patient implant of the Gore TAG Conformable Thoracic Stent Graft...
First Patient Treated in U.S. Feasibility Study of LimFlow Critical Limb Ischemia Device
News | Peripheral Artery Disease (PAD)| July 17, 2017
LimFlow SA announced enrollment of the first patient in the U.S. feasibility study of the LimFlow Percutaneous Deep...
FDA Approves Six-Month Primary Endpoint for Tack Endovascular System in Below the Knee Disease
News | Stents Peripheral| July 14, 2017
Intact Vascular Inc. announced the U.S. Food and Drug Administration (FDA) approved an Investigational Device Exemption...
Philips Announces Relaunch of Pioneer Plus IVUS-Guided Catheter
News | Chronic Total Occlusion (CTO)| June 28, 2017
June 28, 2017 — Royal Philips recently announced the relaunch of its Pioneer Plus...
Overlay Init